Two Sigma Investments’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-54,735
Closed -$1.82M 3588
2024
Q3
$1.82M Buy
54,735
+4,435
+9% +$153K ﹤0.01% 1737
2024
Q2
$1.36M Sell
50,300
-56,585
-53% -$1.12M ﹤0.01% 1800
2024
Q1
$2.31M Buy
+106,885
New +$2.33M 0.01% 1377

Two Sigma Investments's LBPH Position: Q4 2024 in Review

Two Sigma Investments sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 54,735 shares — an estimated $1.82M sold.

Two Sigma Investments first reported a position in LBPH in Q1 2024 and held it in 3 quarters. The position peaked at $2.31M in Q1 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

  • Two Sigma Investments reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Investments sold 54,735 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $1.82M.
  • Two Sigma Investments first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
  • Two Sigma Investments's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $2.31M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Two Sigma Investments's 13F filing for Q4 2024, filed 14 Feb 2025.